ID   RFWD2_HUMAN             Reviewed;         731 AA.
AC   Q8NHY2; E9PKI0; Q504W6; Q6H103; Q9H6L7; X5D9B4;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 143.
DE   RecName: Full=E3 ubiquitin-protein ligase RFWD2;
DE            EC=2.3.2.27;
DE   AltName: Full=Constitutive photomorphogenesis protein 1 homolog;
DE            Short=hCOP1;
DE   AltName: Full=RING finger and WD repeat domain protein 2;
DE   AltName: Full=RING finger protein 200;
DE   AltName: Full=RING-type E3 ubiquitin transferase RFWD2 {ECO:0000305};
GN   Name=RFWD2; Synonyms=COP1, RNF200;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), FUNCTION,
RP   HOMODIMERIZATION, AND SUBCELLULAR LOCATION.
RX   PubMed=12466024; DOI=10.1186/1471-2121-3-30;
RA   Yi C., Wang H., Wei N., Deng X.-W.;
RT   "An initial biochemical and cell biological characterization of the
RT   mammalian homologue of a central plant developmental switch, COP1.";
RL   BMC Cell Biol. 3:30-30(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, INTERACTION WITH JUN; JUNB AND JUND, AND
RP   MUTAGENESIS OF 111-ARG--ARG-113; CYS-136 AND CYS-139.
RX   PubMed=12615916; DOI=10.1074/jbc.M212681200;
RA   Bianchi E., Denti S., Catena R., Rossetti G., Polo S., Gasparian S.,
RA   Putignano S., Rogge L., Pardi R.;
RT   "Characterization of human constitutive photomorphogenesis protein 1,
RT   a RING finger ubiquitin ligase that interacts with Jun transcription
RT   factors and modulates their transcriptional activity.";
RL   J. Biol. Chem. 278:19682-19690(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, ALTERNATIVE SPLICING, COMPONENT OF THE DCX
RP   DET1-COP1 COMPLEX WITH RBX1; CUL4A; DET1 AND DDB1, AND MUTAGENESIS OF
RP   CYS-136 AND CYS-139.
RX   PubMed=14739464; DOI=10.1126/science.1093549;
RA   Wertz I.E., O'Rourke K.M., Zhang Z., Dornan D., Arnott D.,
RA   Deshaies R.J., Dixit V.M.;
RT   "Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin
RT   ligase.";
RL   Science 303:1371-1374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Brain;
RX   PubMed=24722188; DOI=10.1038/ncomms4650;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Hepatoma, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, INDUCTION, AND INTERACTION WITH TP53.
RX   PubMed=15103385; DOI=10.1038/nature02514;
RA   Dornan D., Wertz I., Shimizu H., Arnott D., Frantz G.D., Dowd P.,
RA   O'Rourke K., Koeppen H., Dixit V.M.;
RT   "The ubiquitin ligase COP1 is a critical negative regulator of p53.";
RL   Nature 429:86-92(2004).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORM 4), AND SUBUNIT.
RX   PubMed=17968316; DOI=10.1038/sj.onc.1210892;
RA   Savio M.G., Rotondo G., Maglie S., Rossetti G., Bender J.R., Pardi R.;
RT   "COP1D, an alternatively spliced constitutive photomorphogenic-1
RT   (COP1) product, stabilizes UV stress-induced c-Jun through inhibition
RT   of full-length COP1.";
RL   Oncogene 27:2401-2411(2008).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH TP53.
RX   PubMed=19837670; DOI=10.1074/jbc.M109.056499;
RA   Li D.Q., Divijendra Natha Reddy S., Pakala S.B., Wu X., Zhang Y.,
RA   Rayala S.K., Kumar R.;
RT   "MTA1 coregulator regulates p53 stability and function.";
RL   J. Biol. Chem. 284:34545-34552(2009).
RN   [12]
RP   FUNCTION, INTERACTION WITH MTA1, MUTAGENESIS OF CYS-136; CYS-139;
RP   CYS-156 AND CYS-159, AND AUTOUBIQUITINATION.
RX   PubMed=19805145; DOI=10.1073/pnas.0908027106;
RA   Li D.Q., Ohshiro K., Reddy S.D., Pakala S.B., Lee M.H., Zhang Y.,
RA   Rayala S.K., Kumar R.;
RT   "E3 ubiquitin ligase COP1 regulates the stability and functions of
RT   MTA1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:17493-17498(2009).
RN   [13]
RP   INTERACTION WITH TRIB1.
RX   PubMed=20410507; DOI=10.1182/blood-2009-07-229450;
RA   Dedhia P.H., Keeshan K., Uljon S., Xu L., Vega M.E., Shestova O.,
RA   Zaks-Zilberman M., Romany C., Blacklow S.C., Pear W.S.;
RT   "Differential ability of Tribbles family members to promote
RT   degradation of C/EBPalpha and induce acute myelogenous leukemia.";
RL   Blood 116:1321-1328(2010).
RN   [14]
RP   FUNCTION, INTERACTION WITH COPS6 AND SFN, AND MUTAGENESIS OF CYS-136
RP   AND CYS-139.
RX   PubMed=21625211; DOI=10.1038/onc.2011.192;
RA   Choi H.H., Gully C., Su C.H., Velazquez-Torres G., Chou P.C.,
RA   Tseng C., Zhao R., Phan L., Shaiken T., Chen J., Yeung S.C., Lee M.H.;
RT   "COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3
RT   ubiquitin ligase for 14-3-3sigma.";
RL   Oncogene 30:4791-4801(2011).
RN   [15] {ECO:0000244|PDB:5HQG, ECO:0000244|PDB:5IGQ}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 376-731 ALONE OR IN COMPLEX
RP   WITH A TRIB1 PEPTIDE, FUNCTION, DOMAIN, INTERACTION WITH TRIB1 AND
RP   TRIB2, AND ENZYME REGULATION.
RX   PubMed=27041596; DOI=10.1016/j.str.2016.03.002;
RA   Uljon S., Xu X., Durzynska I., Stein S., Adelmant G., Marto J.A.,
RA   Pear W.S., Blacklow S.C.;
RT   "Structural basis for substrate selectivity of the E3 ligase COP1.";
RL   Structure 24:687-696(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination
CC       and subsequent proteasomal degradation of target proteins. E3
CC       ubiquitin ligases accept ubiquitin from an E2 ubiquitin-
CC       conjugating enzyme in the form of a thioester and then directly
CC       transfers the ubiquitin to targeted substrates. Involved in JUN
CC       ubiquitination and degradation. Directly involved in p53 (TP53)
CC       ubiquitination and degradation, thereby abolishing p53-dependent
CC       transcription and apoptosis. Ubiquitinates p53 independently of
CC       MDM2 or RCHY1. Probably mediates E3 ubiquitin ligase activity by
CC       functioning as the essential RING domain subunit of larger E3
CC       complexes. In contrast, it does not constitute the catalytic RING
CC       subunit in the DCX DET1-COP1 complex that negatively regulates
CC       JUN, the ubiquitin ligase activity being mediated by RBX1.
CC       Involved in 14-3-3 protein sigma/SFN ubiquitination and
CC       proteasomal degradation, leading to AKT activation and promotion
CC       of cell survival. Ubiquitinates MTA1 leading to its proteasomal
CC       degradation. Upon binding to TRIB1, ubiquitinates CEBPA, which
CC       lacks a canonical COP1-binding motif (Probable).
CC       {ECO:0000269|PubMed:12466024, ECO:0000269|PubMed:12615916,
CC       ECO:0000269|PubMed:14739464, ECO:0000269|PubMed:15103385,
CC       ECO:0000269|PubMed:19805145, ECO:0000269|PubMed:19837670,
CC       ECO:0000269|PubMed:21625211, ECO:0000303|PubMed:27041596}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- ENZYME REGULATION: TRIB1 competes with substrates for RFWD2
CC       binding. {ECO:0000269|PubMed:27041596}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homodimer. Homodimerization is mediated by the coiled
CC       coil domain. Component of the DCX DET1-COP1 ubiquitin ligase
CC       complex at least composed of RBX1, DET1, DDB1, CUL4A and COP1.
CC       Isoform 2 does not interact with CUL4A but still binds to RBX1,
CC       suggesting that the interaction may be mediated by another cullin
CC       protein. Isoform 1 and isoform 2 interact with CUL5 but not with
CC       CUL1, CUL2 not CUL3. Interacts with bZIP transcription factors
CC       JUN, JUNB and JUND but not with FOS, ATF2 nor XBP1. Interacts with
CC       p53 (TP53). Interacts with COPS6; this interaction stabilizes
CC       RFWD2 through reducing its auto-ubiquitination and decelerating
CC       its turnover rate. Interacts with SFN; this interaction leads to
CC       SFN degradation. Isoform 4 forms heterodimers with isoform 1,
CC       preventing its association with DET1. Interacts with p53/TP53 and
CC       MTA1. Interacts with TRIB1 (via C-terminus) and TRIB2
CC       (PubMed:20410507, PubMed:27041596). {ECO:0000269|PubMed:12615916,
CC       ECO:0000269|PubMed:15103385, ECO:0000269|PubMed:17968316,
CC       ECO:0000269|PubMed:19805145, ECO:0000269|PubMed:19837670,
CC       ECO:0000269|PubMed:20410507, ECO:0000269|PubMed:21625211,
CC       ECO:0000269|PubMed:27041596}.
CC   -!- INTERACTION:
CC       Q7L5N1:COPS6; NbExp=3; IntAct=EBI-1176214, EBI-486838;
CC       P14921-1:ETS1; NbExp=3; IntAct=EBI-1176214, EBI-913224;
CC       P15036:ETS2; NbExp=2; IntAct=EBI-1176214, EBI-1646991;
CC       P31947:SFN; NbExp=6; IntAct=EBI-1176214, EBI-476295;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle. Cytoplasm. Note=In the
CC       nucleus, it forms nuclear speckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8NHY2-1; Sequence=Displayed;
CC       Name=2; Synonyms=delta24;
CC         IsoId=Q8NHY2-2; Sequence=VSP_012024, VSP_012025;
CC       Name=3;
CC         IsoId=Q8NHY2-3; Sequence=VSP_012026, VSP_012027;
CC         Note=No experimental confirmation available.;
CC       Name=4; Synonyms=COP1D;
CC         IsoId=Q8NHY2-4; Sequence=VSP_012025;
CC         Note=Unable to associate with other components of the CRL
CC         complex. Acts as a dominant-negative.;
CC       Name=5; Synonyms=E;
CC         IsoId=Q8NHY2-5; Sequence=VSP_055894, VSP_055895;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed at low level. Expressed
CC       at higher level in testis, placenta, skeletal muscle and heart.
CC       {ECO:0000269|PubMed:12615916, ECO:0000269|PubMed:15103385}.
CC   -!- INDUCTION: By p53/TP53. {ECO:0000269|PubMed:15103385}.
CC   -!- DOMAIN: The RING finger domain, in addition to its role in
CC       ubiquitination, functions as a structural scaffold to bring two
CC       clusters of positive-charged residues within spatial proximity to
CC       mimic a bipartite nuclear localization signal (NLS) (By
CC       similarity). {ECO:0000250|UniProtKB:Q9R1A8}.
CC   -!- DOMAIN: The WD40 domain (386-731) is necessary and sufficient for
CC       TRIB1 binding (PubMed:27041596). {ECO:0000269|PubMed:27041596}.
CC   -!- PTM: Autoubiquitinated. MTA1 destabilizes it by promoting its
CC       autoubiquitination. {ECO:0000269|PubMed:19805145}.
CC   -!- SIMILARITY: Belongs to the COP1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF508940; AAM34692.1; -; mRNA.
DR   EMBL; BK000438; DAA01050.1; -; Genomic_DNA.
DR   EMBL; AF527539; AAQ08989.1; -; mRNA.
DR   EMBL; AY509921; AAS82851.1; -; mRNA.
DR   EMBL; KJ534928; AHW56568.1; -; mRNA.
DR   EMBL; KJ535076; AHW56715.1; -; mRNA.
DR   EMBL; AK025789; BAB15239.1; -; mRNA.
DR   EMBL; AK314750; BAG37289.1; -; mRNA.
DR   EMBL; AL359265; CAH71140.1; -; Genomic_DNA.
DR   EMBL; AL162736; CAH71140.1; JOINED; Genomic_DNA.
DR   EMBL; AL513329; CAH71140.1; JOINED; Genomic_DNA.
DR   EMBL; AL590723; CAH71140.1; JOINED; Genomic_DNA.
DR   EMBL; AL513329; CAH72425.1; -; Genomic_DNA.
DR   EMBL; AL162736; CAH72425.1; JOINED; Genomic_DNA.
DR   EMBL; AL359265; CAH72425.1; JOINED; Genomic_DNA.
DR   EMBL; AL590723; CAH72425.1; JOINED; Genomic_DNA.
DR   EMBL; AL162736; CAH73625.1; -; Genomic_DNA.
DR   EMBL; AL359265; CAH73625.1; JOINED; Genomic_DNA.
DR   EMBL; AL513329; CAH73625.1; JOINED; Genomic_DNA.
DR   EMBL; AL590723; CAH73625.1; JOINED; Genomic_DNA.
DR   EMBL; AL590723; CAI14643.1; -; Genomic_DNA.
DR   EMBL; AL162736; CAI14643.1; JOINED; Genomic_DNA.
DR   EMBL; AL359265; CAI14643.1; JOINED; Genomic_DNA.
DR   EMBL; AL513329; CAI14643.1; JOINED; Genomic_DNA.
DR   EMBL; CH471067; EAW91000.1; -; Genomic_DNA.
DR   EMBL; BC094728; AAH94728.1; -; mRNA.
DR   CCDS; CCDS30944.1; -. [Q8NHY2-1]
DR   CCDS; CCDS44279.1; -. [Q8NHY2-2]
DR   RefSeq; NP_001001740.1; NM_001001740.3. [Q8NHY2-2]
DR   RefSeq; NP_001273573.1; NM_001286644.1.
DR   RefSeq; NP_071902.2; NM_022457.6. [Q8NHY2-1]
DR   UniGene; Hs.523744; -.
DR   PDB; 5HQG; X-ray; 2.00 A; A=376-731.
DR   PDB; 5IGQ; X-ray; 3.90 A; A/B/C/D/E/F=386-731.
DR   PDBsum; 5HQG; -.
DR   PDBsum; 5IGQ; -.
DR   ProteinModelPortal; Q8NHY2; -.
DR   SMR; Q8NHY2; -.
DR   BioGrid; 122136; 92.
DR   DIP; DIP-36661N; -.
DR   IntAct; Q8NHY2; 25.
DR   MINT; MINT-260162; -.
DR   STRING; 9606.ENSP00000356641; -.
DR   iPTMnet; Q8NHY2; -.
DR   PhosphoSitePlus; Q8NHY2; -.
DR   DMDM; 55976539; -.
DR   EPD; Q8NHY2; -.
DR   MaxQB; Q8NHY2; -.
DR   PaxDb; Q8NHY2; -.
DR   PeptideAtlas; Q8NHY2; -.
DR   PRIDE; Q8NHY2; -.
DR   DNASU; 64326; -.
DR   Ensembl; ENST00000308769; ENSP00000310943; ENSG00000143207. [Q8NHY2-2]
DR   Ensembl; ENST00000367669; ENSP00000356641; ENSG00000143207. [Q8NHY2-1]
DR   Ensembl; ENST00000474194; ENSP00000433517; ENSG00000143207. [Q8NHY2-5]
DR   GeneID; 64326; -.
DR   KEGG; hsa:64326; -.
DR   UCSC; uc001gku.3; human. [Q8NHY2-1]
DR   CTD; 64326; -.
DR   DisGeNET; 64326; -.
DR   GeneCards; RFWD2; -.
DR   HGNC; HGNC:17440; RFWD2.
DR   MIM; 608067; gene.
DR   neXtProt; NX_Q8NHY2; -.
DR   OpenTargets; ENSG00000143207; -.
DR   PharmGKB; PA134952161; -.
DR   eggNOG; ENOG410IE71; Eukaryota.
DR   eggNOG; ENOG410XNTU; LUCA.
DR   GeneTree; ENSGT00570000079069; -.
DR   HOGENOM; HOG000006123; -.
DR   HOVERGEN; HBG054995; -.
DR   InParanoid; Q8NHY2; -.
DR   KO; K10143; -.
DR   OMA; FSTRMTR; -.
DR   OrthoDB; EOG091G0ERB; -.
DR   PhylomeDB; Q8NHY2; -.
DR   TreeFam; TF328912; -.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   SignaLink; Q8NHY2; -.
DR   SIGNOR; Q8NHY2; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RFWD2; human.
DR   GeneWiki; RFWD2; -.
DR   GenomeRNAi; 64326; -.
DR   PRO; PR:Q8NHY2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143207; -.
DR   CleanEx; HS_RFWD2; -.
DR   ExpressionAtlas; Q8NHY2; baseline and differential.
DR   Genevisible; Q8NHY2; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IMP:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 2.130.10.10; -; 3.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00400; WD40; 5.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 2.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasm; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway; WD repeat;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    731       E3 ubiquitin-protein ligase RFWD2.
FT                                /FTId=PRO_0000055879.
FT   REPEAT      419    458       WD 1.
FT   REPEAT      468    508       WD 2.
FT   REPEAT      511    551       WD 3.
FT   REPEAT      553    593       WD 4.
FT   REPEAT      597    635       WD 5.
FT   REPEAT      638    677       WD 6.
FT   REPEAT      691    729       WD 7.
FT   ZN_FING     136    174       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION      643    645       Interaction with TRIB1.
FT                                {ECO:0000269|PubMed:27041596}.
FT   COILED      233    301       {ECO:0000255}.
FT   MOTIF       109    113       Nuclear localization signal 1.
FT   MOTIF       195    206       Nuclear localization signal 2.
FT   MOTIF       235    245       Nuclear export signal. {ECO:0000250}.
FT   COMPBIAS      2    110       Ser-rich.
FT   SITE        472    472       Interaction with TRIB1.
FT                                {ECO:0000269|PubMed:27041596}.
FT   SITE        491    491       Interaction with TRIB1.
FT                                {ECO:0000269|PubMed:27041596}.
FT   VAR_SEQ       1    264       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012026.
FT   VAR_SEQ     157    157       Y -> E (in isoform 5).
FT                                {ECO:0000303|PubMed:24722188}.
FT                                /FTId=VSP_055894.
FT   VAR_SEQ     158    731       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:24722188}.
FT                                /FTId=VSP_055895.
FT   VAR_SEQ     211    214       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14739464}.
FT                                /FTId=VSP_012024.
FT   VAR_SEQ     277    296       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:14739464}.
FT                                /FTId=VSP_012025.
FT   VAR_SEQ     342    342       Q -> QAGVQWRYLGSLQPPPPRYKRFSCLTLPSSWDYRRL
FT                                PPHL (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012027.
FT   MUTAGEN     111    113       RKR->AKA: Abolishes localization to the
FT                                nucleus. {ECO:0000269|PubMed:12615916}.
FT   MUTAGEN     136    136       C->A: Abolishes p53 ubiquitination and
FT                                degradation but not that of JUN; when
FT                                associated with A-139.
FT                                {ECO:0000269|PubMed:12615916,
FT                                ECO:0000269|PubMed:14739464,
FT                                ECO:0000269|PubMed:19805145,
FT                                ECO:0000269|PubMed:21625211}.
FT   MUTAGEN     136    136       C->S: Loss of SFN and MTA1 ubiquitination
FT                                and degradation; when associated with S-
FT                                139. Loss of stabilization by COPS6; when
FT                                associated with S-139.
FT                                {ECO:0000269|PubMed:12615916,
FT                                ECO:0000269|PubMed:14739464,
FT                                ECO:0000269|PubMed:19805145,
FT                                ECO:0000269|PubMed:21625211}.
FT   MUTAGEN     139    139       C->A: Abolishes p53 ubiquitination and
FT                                degradation but not that of JUN; when
FT                                associated with A-136.
FT                                {ECO:0000269|PubMed:12615916,
FT                                ECO:0000269|PubMed:14739464,
FT                                ECO:0000269|PubMed:19805145,
FT                                ECO:0000269|PubMed:21625211}.
FT   MUTAGEN     139    139       C->S: Loss of SFN and MTA1 ubiquitination
FT                                and degradation; when associated with S-
FT                                136. Loss of stabilization by COPS6; when
FT                                associated with S-136.
FT                                {ECO:0000269|PubMed:12615916,
FT                                ECO:0000269|PubMed:14739464,
FT                                ECO:0000269|PubMed:19805145,
FT                                ECO:0000269|PubMed:21625211}.
FT   MUTAGEN     156    156       C->S: Loss of MTA1 ubiquitination and
FT                                degradation; when associated with S-159.
FT                                {ECO:0000269|PubMed:19805145}.
FT   MUTAGEN     159    159       C->S: Loss of MTA1 ubiquitination and
FT                                degradation; when associated with S-156.
FT                                {ECO:0000269|PubMed:19805145}.
FT   HELIX       392    399       {ECO:0000244|PDB:5HQG}.
FT   STRAND      404    412       {ECO:0000244|PDB:5HQG}.
FT   STRAND      424    429       {ECO:0000244|PDB:5HQG}.
FT   STRAND      433    440       {ECO:0000244|PDB:5HQG}.
FT   STRAND      443    449       {ECO:0000244|PDB:5HQG}.
FT   HELIX       450    453       {ECO:0000244|PDB:5HQG}.
FT   STRAND      464    468       {ECO:0000244|PDB:5HQG}.
FT   STRAND      473    478       {ECO:0000244|PDB:5HQG}.
FT   STRAND      485    490       {ECO:0000244|PDB:5HQG}.
FT   STRAND      495    499       {ECO:0000244|PDB:5HQG}.
FT   TURN        500    502       {ECO:0000244|PDB:5HQG}.
FT   STRAND      505    509       {ECO:0000244|PDB:5HQG}.
FT   STRAND      516    521       {ECO:0000244|PDB:5HQG}.
FT   STRAND      528    533       {ECO:0000244|PDB:5HQG}.
FT   STRAND      536    542       {ECO:0000244|PDB:5HQG}.
FT   STRAND      549    553       {ECO:0000244|PDB:5HQG}.
FT   STRAND      558    563       {ECO:0000244|PDB:5HQG}.
FT   STRAND      570    575       {ECO:0000244|PDB:5HQG}.
FT   STRAND      580    584       {ECO:0000244|PDB:5HQG}.
FT   STRAND      592    595       {ECO:0000244|PDB:5HQG}.
FT   STRAND      602    617       {ECO:0000244|PDB:5HQG}.
FT   TURN        618    620       {ECO:0000244|PDB:5HQG}.
FT   STRAND      621    626       {ECO:0000244|PDB:5HQG}.
FT   STRAND      633    636       {ECO:0000244|PDB:5HQG}.
FT   STRAND      642    644       {ECO:0000244|PDB:5HQG}.
FT   STRAND      648    651       {ECO:0000244|PDB:5HQG}.
FT   STRAND      654    658       {ECO:0000244|PDB:5HQG}.
FT   STRAND      662    668       {ECO:0000244|PDB:5HQG}.
FT   STRAND      676    679       {ECO:0000244|PDB:5HQG}.
FT   STRAND      700    705       {ECO:0000244|PDB:5HQG}.
FT   STRAND      709    711       {ECO:0000244|PDB:5HQG}.
FT   STRAND      715    720       {ECO:0000244|PDB:5HQG}.
FT   STRAND      723    731       {ECO:0000244|PDB:5HQG}.
SQ   SEQUENCE   731 AA;  80474 MW;  C4B262268D01FA00 CRC64;
     MSGSRQAGSG SAGTSPGSSA ASSVTSASSS LSSSPSPPSV AVSAAALVSG GVAQAAGSGG
     LGGPVRPVLV APAVSGSGGG AVSTGLSRHS CAARPSAGVG GSSSSLGSGS RKRPLLAPLC
     NGLINSYEDK SNDFVCPICF DMIEEAYMTK CGHSFCYKCI HQSLEDNNRC PKCNYVVDNI
     DHLYPNFLVN ELILKQKQRF EEKRFKLDHS VSSTNGHRWQ IFQDWLGTDQ DNLDLANVNL
     MLELLVQKKK QLEAESHAAQ LQILMEFLKV ARRNKREQLE QIQKELSVLE EDIKRVEEMS
     GLYSPVSEDS TVPQFEAPSP SHSSIIDSTE YSQPPGFSGS SQTKKQPWYN STLASRRKRL
     TAHFEDLEQC YFSTRMSRIS DDSRTASQLD EFQECLSKFT RYNSVRPLAT LSYASDLYNG
     SSIVSSIEFD RDCDYFAIAG VTKKIKVYEY DTVIQDAVDI HYPENEMTCN SKISCISWSS
     YHKNLLASSD YEGTVILWDG FTGQRSKVYQ EHEKRCWSVD FNLMDPKLLA SGSDDAKVKL
     WSTNLDNSVA SIEAKANVCC VKFSPSSRYH LAFGCADHCV HYYDLRNTKQ PIMVFKGHRK
     AVSYAKFVSG EEIVSASTDS QLKLWNVGKP YCLRSFKGHI NEKNFVGLAS NGDYIACGSE
     NNSLYLYYKG LSKTLLTFKF DTVKSVLDKD RKEDDTNEFV SAVCWRALPD GESNVLIAAN
     SQGTIKVLEL V
//
